Cartherics to present and exhibit at Emergence 2024

By Karen Loudon / February 22, 2024
Cartherics is pleased to announce that it will be attending Emergence 2024 – The Era of Abundance investment conference at...
Read More

Cartherics’ CEO discusses the future of solid tumour therapy

By Karen Loudon / February 15, 2024
Cartherics’ CEO, Prof. Alan Trounson AO was recently interviewed by Wholesale Investor to discuss the company’s latest developments and the...
Read More

Ovarian cancer: Biotech company Cartherics to start human trials of new drug

By Karen Loudon / February 12, 2024
There’s an urgent need for new treatment options for ovarian cancer patients who are often diagnosed at advanced stages when...
Read More

Positive pre-IND meeting with US FDA for new ovarian cancer cell therapy

By Karen Loudon / February 1, 2024
Melbourne, Australia, 1 February 2024 –  Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the...
Read More

Cartherics to present at Australia Biologics Festival 2024

By Karen Loudon / January 23, 2024
Cartherics is pleased to announce that Dr Ian Nisbet, Chief Operating Officer, will be presenting at Australia Biologics 2024 at...
Read More

Buoyant Life Sciences Sector Emerges Stronger

By Karen Loudon / December 18, 2023
BioSpectrum Asia’s cover story in its December edition reflects on the advancement and changes that have shaped the industry in...
Read More

Chimeric Antigen Receptor (CAR) – Natural Killer (NK) Cells – Looking good for cancer therapy

By Karen Loudon / November 28, 2023
As published in Drug Target Review  Professor Alan Trounson, AO Dr Huimin Cao Dr Aleta Pupovac The suitability of NK...
Read More

Rearming the body to fight cancer

By Karen Loudon / November 15, 2023
Cartherics is currently undertaking a new capital raise to initiate clinical trials for its lead allogeneic cell therapy for ovarian...
Read More

Importance of building Australia-China biotech collaborations

By Karen Loudon / November 1, 2023
China is Australia’s greatest two-way trading partner in products and services, making up close to one-third of the nation's international...
Read More

Life Science Success podcast with Prof. Alan Trounson

By Karen Loudon / October 20, 2023
Cartherics’ CEO, Prof. Alan Trounson, was recently a guest on Life Science Success podcast. Hosted by Dr Don Davies, this...
Read More

Cartherics appoints new Chief Scientific Officer

By Karen Loudon / October 17, 2023
Melbourne, Australia, 17 October 2023 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for...
Read More

Ovarian cancer is not ovarian cancer

By Karen Loudon / October 3, 2023
Cartherics’ Dr Ian Nisbet (Chief Operating Officer) and Kathy Skoff (Clinical Trials Manager) recently attended an ovarian cancer symposium in...
Read More

Combining new and existing immunity: a 3D approach to killing cancer

By Karen Loudon / September 25, 2023
by Richard Boyd and Aleta Pupovac A question which has long baffled scientists, frustrated clinicians and devastated patients is why...
Read More

Heather Hawkins Ovarian Cancer Journey

By Karen Loudon / August 24, 2023
Heather Hawkins, Cartherics Board Advisor and patient advocate, shares her personal journey with ovarian cancer in the hope that it...
Read More

Bio Connections Australia 2023 promotes science commercialisation

By Karen Loudon / July 31, 2023
Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world...
Read More
1 2 3 11